Robert Ang is the founder of Vor Biopharma. Vor Biopharma has raised $217M in total funding. Latest round: Series A. Based in Cambridge, MA.
Robert Ang is the CEO of Vor Biopharma, a biotechnology company focused on developing eHSC-based therapies for blood cancers and autoimmune diseases. He previously served as the Chief Business Officer at Neon Biopharma before joining Vor three years after its founding. Ang leads Vor's clinical program Trem-cel (formerly VOR33), which is in Phase 1/2a trials for acute myeloid leukemia.
Full founder directory · Investor directory · Company funding database · Fundraising library